Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Daitobo Co., Ltd. (3202.T)
Tokyo, JP
Founded in Tokyo, Japan, in 1896, Daitobo Co., Ltd. is a multifaceted enterprise with operations spanning both domestic and international markets. Its diverse business portfolio includes fashion apparel and uniforms, real estate development and management, and various healthcare-related products and services. In the realm of fashion and uniforms, Daitobo specializes in textile fabrication, offering original equipment manufacturer (OEM) services for fabrics and original design manufacturer (ODM) services for knitwear, utilizing both premium and Chinese materials. The company is also a key supplier of uniforms made from wool, cotton, and synthetic fibers, including those for government agencies. Its real estate division is actively involved in the investment and development of commercial properties, residential leasing, and the acquisition and sale of real estate assets. The healthcare segment focuses on manufacturing health-enhancing products, such as EWOOL sleeping items and other specialized goods under the Mixley Wool brand. Daitobo also engages in the wholesale and sale of futon-style home medical equipment and provides health food products like Kenyosen and SpoLife LN2. Furthermore, the company extends its manufacturing capabilities to general bedding products and offers broad OEM services, particularly from its operations in China. The company adopted its current name, Daitobo Co., Ltd., in September 2016, having previously been known as Daito Woolen Spinning & Weaving Co Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -0.79% | +0.81% | -4.58% | +12.61% | +9.65% | +17.92% | +37.36% | +23.76% | +92.31% | +68.92% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Apparel - Manufacturers: +3.9%-2.3% Q1'26: -0.2% (vs Q1'25)
-
EPS growth Apparel - Manufacturers: +10.5%+65.6% ★ Q1'26: +95.2% (vs Q1'25)
-
FCF margin FCF growth · Apparel - Manufacturers: +37.5%+14.0% ★ Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Apparel - Manufacturers: +8.0%+7.7% Q1'26: +7.7% (vs Q1'25)
-
ROIC Apparel - Manufacturers: +6.0%+1.8% Q1'26: +1.4% (vs Q1'25)
-
Share dilution Apparel - Manufacturers: +0.0%-0.3% ★ Q1'26: -4.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Apparel - Manufacturers: 0.02×11.87× Q1'26: 11.62× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-01 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-30 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-28 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-27 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-24 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-23 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-22 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-16 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 2/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kazuhiro Yamauchi | Chief Executive Officer, President & Representative Director | — | male |
| Shinji Moriguchi | Executive Officer and GM of the HR & General Affairs Dep. of the Business Mngt. Division | — | male |
| Shiro Nomura | Senior Executive Officer, GM of Healthcare Business Division & Director | — | male |
| Shogo Saegusa | Managing Executive Officer, Head of Business Management Division, Chief Financial Officer & Director | — | male |
| Wataru Iida | Senior Executive Officer & GM of Commercial Facilities Business Headquarters | — | — |
| Wataru Tsunoda | Executive Officer & GM of Fibers Business Division | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 3202.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
